Girish B. Nair, MD, MS, FACP, FCCP
 
Professor of Medicine
Boehringer-Ingelheim Pulmonary Endowed Research Professor

Director Interstitial Lung Disease Program
Division of Pulmonary, Critical Care & Sleep Medicine

University of Kentucky

In person and via Zoom

Upon completion of this activity, participants will be able to:

• Review the current diagnostic & therapeutic updates in ILD
• Evaluate the management framework of patients diagnosed with ILD in 2025
• Employ the newer integrative workup and prognostic methods for patients with ILD

Disclosure of Financial Interest Summary

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

Girish Nair, speaker for this educational event, was on the Disease State Speaker's Bureau for Boehringer Ingelheim. 

All of the relevant financial relationships listed for these individuals have been mitigated.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.